Killing tumours by ceramide-induced apoptosis: a critique of available drugs - PubMed
- ️Wed Jan 01 2003
Review
Killing tumours by ceramide-induced apoptosis: a critique of available drugs
Norman S Radin. Biochem J. 2003.
Abstract
Over 1000 research papers have described the production of programmed cell death (apoptosis) by interventions that elevate the cell content of ceramide (Cer). Other interventions, which lower cellular Cer, have been found to interfere with apoptosis induced by other agents. Some studies have shown that slowing the formation of proliferation-stimulating sphingolipids also induces apoptosis. These relationships are due to the two different aspects of Cer: Cer itself produces apoptosis, but metabolic conversion of Cer into either sphingosine 1-phosphate or glucosphingolipids leads to cell proliferation. The balance between these two aspects is missing in cancer cells, and yet intervention by stimulating or blocking only one or two of the pathways in Cer metabolism is very likely to fail. This results from two properties of cancer cells: their high mutation rate and the preferential survival of the most malignant cells. Tumours treated with only one or two drugs that elevate Cer can adjust the uncontrolled processes to either maintain or to 'aggravate' the excessive growth, angiogenesis and metastasis characteristics of tumours. These treatments might simply elevate the production of growth factors, receptors and other substances that reduce the effectiveness of Cer. Tumour cells that do not adapt in this way undergo apoptosis, leaving the adapted cells free to grow and, ultimately, to 'subdue' their host. Thus it is important to kill every type of cancer cell present in the tumour rapidly and simultaneously, using as many different agents to control as many pathways as possible. To aid this approach, this article catalogues many of the drugs that act on different aspects of Cer metabolism. The techniques described here may lead to the development of practical chemotherapy for cancer and other diseases of excess proliferation.
Similar articles
-
Poly-drug cancer therapy based on ceramide.
Radin NS. Radin NS. Eksp Onkol. 2004 Mar;26(1):3-10. Eksp Onkol. 2004. PMID: 15112572 Review.
-
Novel ceramide analogs as potential chemotherapeutic agents in breast cancer.
Struckhoff AP, Bittman R, Burow ME, Clejan S, Elliott S, Hammond T, Tang Y, Beckman BS. Struckhoff AP, et al. J Pharmacol Exp Ther. 2004 May;309(2):523-32. doi: 10.1124/jpet.103.062760. Epub 2004 Jan 23. J Pharmacol Exp Ther. 2004. PMID: 14742741
-
Active cell death (apoptosis) and cellular proliferation as indicators of exposure to carcinogens.
Schulte-Hermann R, Bursch W, Marian B, Grasl-Kraupp B. Schulte-Hermann R, et al. IARC Sci Publ. 1999;(146):273-85. IARC Sci Publ. 1999. PMID: 10353391 Review.
-
Awad AB, Barta SL, Fink CS, Bradford PG. Awad AB, et al. Mol Nutr Food Res. 2008 Apr;52(4):419-26. doi: 10.1002/mnfr.200700222. Mol Nutr Food Res. 2008. PMID: 18338406
-
Cell death by apoptosis and cancer chemotherapy.
Indap MA, Rao SG. Indap MA, et al. Natl Med J India. 1995 Mar-Apr;8(2):65-7. Natl Med J India. 1995. PMID: 7735063 Review.
Cited by
-
Nikolova GS, Haufe G. Nikolova GS, et al. Beilstein J Org Chem. 2008;4:12. doi: 10.3762/bjoc.4.12. Epub 2008 Apr 25. Beilstein J Org Chem. 2008. PMID: 18941484 Free PMC article.
-
Vejselova D, Kutlu HM, Kuş G. Vejselova D, et al. Cytotechnology. 2016 Dec;68(6):2721-2728. doi: 10.1007/s10616-016-9997-7. Epub 2016 Jul 5. Cytotechnology. 2016. PMID: 27380965 Free PMC article.
-
Translational Aspects of Sphingolipid Metabolism in Renal Disorders.
Abou Daher A, El Jalkh T, Eid AA, Fornoni A, Marples B, Zeidan YH. Abou Daher A, et al. Int J Mol Sci. 2017 Nov 25;18(12):2528. doi: 10.3390/ijms18122528. Int J Mol Sci. 2017. PMID: 29186855 Free PMC article. Review.
-
Basu S, Ma R, Boyle PJ, Mikulla B, Bradley M, Smith B, Basu M, Banerjee S. Basu S, et al. Glycoconj J. 2004;20(9):563-77. doi: 10.1023/B:GLYC.0000043293.46845.07. Glycoconj J. 2004. PMID: 15454695
-
Li J, Yu W, Tiwary R, Park SK, Xiong A, Sanders BG, Kline K. Li J, et al. Cancer Cell Int. 2010 Oct 25;10:40. doi: 10.1186/1475-2867-10-40. Cancer Cell Int. 2010. PMID: 20974006 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources